NRIX biotech catalysts & pipeline

NURIX THERAPEUTICS INC · Data as of 2026-09-08

Upcoming catalysts

2026

Targeting 2026 IND submission for bexobrutideg in inflammatory and autoimmune indications with a new tablet formulation

2026

Updated data from this study are anticipated to be presented at upcoming medical meetings throughout 2026.